Investigator-initiated clinical study of of DSUVIA in patients undergoing cardiac surgery with cardiopulmonary bypass
Latest Information Update: 02 Feb 2024
At a glance
- Drugs Sufentanil (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- 09 Jan 2024 According to Talphera media release, AcelRx Pharmaceuticals changed its name to Talphera, Inc.
- 22 Jan 2021 New trial record
- 19 Jan 2021 According to an AcelRx Pharmaceuticals media release, the study will be conducted at the University Hospitals (UH) Cleveland Medical Center.